Use of Psychotropics in Patients With Hepatic Issues

<p>How to determine whether hepatic impairment can affect drug metabolism? This episode discusses practical considerations when prescribing psychotropic medications for patients with hepatic issues. It also clarifies dosing considerations for specific medications, such as clozapine and valproate, in the context of patients with hepatic issues. </p> <p>Guest: Jonathan Meyer, M.D. <br /> Interviewer: Mohan Gautam, M.D. <br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC191"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/use-of-psychotropics-in-patients-with-hepatic-issues-interview-2655?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC191"> <strong>Earn 0.5 CMEs: Use of Psychotropics in Patients With Hepatic Issues - Interview with Jonathan M. Meyer, M.D.</strong></a></li> </ul>